New Horizons in Dyslipidaemia is a free-to-access, one-day virtual educational event on 12 February 2026, developed for healthcare professionals involved in cardiovascular risk assessment and lipid management.

The programme will explore the rapidly evolving landscape of lipid management, addressing gaps between perceived and actual cardiovascular risk and the underutilisation of effective therapies. Through expert-led sessions, attendees will gain practical, evidence-based insights into lipids and lipoproteins, emerging lipid-lowering treatments, and navigating increasingly complex guidelines to improve lipid target attainment and overcome clinical inertia.

Led by course directors Peter Libby, Kausik Ray and Erik Stroes, this live event will support clinicians in making informed decisions in an era of expanding therapeutic possibilities.

The programme will be submitted to EBAC for 3.5 CME credits (3.5 hours of effective education time), with the option for physicians to convert credits to AMA PRA Category 1 Credits™.